Addex Therapeutics
ADXN
5 hedge funds and large institutions have $106K invested in Addex Therapeutics in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
680% more capital invested
Capital invested by funds: $13.6K → $106K (+$92.2K)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
67% more funds holding
Funds holding: 3 → 5 (+2)
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$110K |
| 2 |
Morgan Stanley
New York
|
+$14.1K |
| 3 |
GI
GAMMA Investing
Foster City,
California
|
+$9.21K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$656 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$9.77K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $84.6K | +$110K | +12,079 | New |
|
|
2
Morgan Stanley
New York
| $13.3K | +$14.1K | +1,547 | +438% |
|
|
GI
3
GAMMA Investing
Foster City,
California
| $7.08K | +$9.21K | +1,011 | New |
|
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $749 | +$656 | +72 | +206% |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $35 | +$46 | +5 | New |
|
|
ACM
6
ADAR1 Capital Management
Austin,
Texas
| – | -$9.77K | -1,000 | Closed |
|
ADXN Hedge Fund Activity: Q4 2024 in Review
5 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q4 2024, worth a combined $106K — up 680% from $13.6K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ADXN positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $110K. The largest seller was ADAR1 Capital Management, exiting entirely with an estimated $9.77K sold.
- 5 institutional investors held Addex Therapeutics (ADXN) as of Q4 2024, up from 3 in Q3 2024.
- Funds reported $106K of Addex Therapeutics stock for Q4 2024, up 680% quarter-over-quarter.
- 3 funds opened new Addex Therapeutics positions in Q4 2024 and 1 closed out, a net change of +2 holders.
- The largest Addex Therapeutics buyer in Q4 2024 was Citadel Advisors, an estimated $110K added.
- The largest Addex Therapeutics seller in Q4 2024 was ADAR1 Capital Management, an estimated $9.77K sold.
Based on aggregated 13F filings for Q4 2024.